Healing and adverse remodelling after acute myocardial infarction: Role of the cellular immune response

Heart

Volumn 98, Issue 18, 2012, Pages 1384-1390

  Van Der Laan, Anja M ^a   Nahrendorf, Matthias ^b   Piek, Jan J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; CHEMOKINE RECEPTOR CCR2; COMPLEMENT FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MACROPHAGE DERIVED CHEMOKINE; MATRIX METALLOPROTEINASE; PEXELIZUMAB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; APOPTOSIS; CELL FUNCTION; CELLULAR IMMUNITY; DEGRADATION; EXTRACELLULAR MATRIX; HEART INFARCTION SIZE; HEART MUSCLE CELL; HUMAN; LYMPHOCYTE; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TISSUE REGENERATION;

BLOOD CELLS; FORECASTING; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; MACROPHAGES; MAST CELLS; MYOCARDIAL INFARCTION; STEM CELLS; VENTRICULAR REMODELING; WOUND HEALING;

EID: 84865180367     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301623     Document Type: Review

References (20)

1. Frangogiannis NG. The mechanistic basis of infarct healing. Antioxid Redox Signal 2006;8 :1907-39. Excellent review providing a detailed overview of the molecular and cellular mechanisms involved in infarct healing. (Pubitemid 46504897)
2. Maekawa Y, Anzai T, Yoshikawa T, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002; 39:241-6. Clinical study demonstrating an important association between the peak monocyte count and adverse LV remodelling following reperfused acute MI. (Pubitemid 34084628)
3. Takahashi T, Hiasa Y, Ohara Y, et al. Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction. Circ J 2008;72:867-72. (Pubitemid 351879904)
4. Granger CB, Mahaffey KW, Weaver WD, et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 2003;108:1184-90. Randomised clinical trial showing no beneficial effect of adjuvant treatment with the C5 complement inhibitor pexelizumab on infarct size in patients undergoing primary percutaneous coronary intervention.
5. Faxon DP, Gibbons RJ, Chronos NA, et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 2002;40:1199-204. Randomised clinical trial demonstrating no reduction of infarct size after treatment with an antibody to the CD11/ CD18 integrin receptor, Hu23F2G, in patients undergoing primary percutaneous coronary intervention.
6. Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037-47. First experimental study showing that monocyte subsets are sequentially mobilised following acute MI in mice and that these subsets have different functions. (Pubitemid 350179569)
7. Tsujioka H, Imanishi T, Ikejima H, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009; 54:130-8. Clinical study demonstrating for the first time an association between the peak level of classical monocytes in blood and myocardial salvage in patients with acute MI, treated with primary percutaneous coronary intervention.
8. van der Laan AM, Hirsch A, Robbers LF, et al. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction monocytes and myocardial infarction. Am Heart J 2012;163 :57-65.e2. Clinical study showing that a high concentration of classical monocytes in blood is associated with impaired functional outcome following primary percutaneous coronary intervention.
9. Dewald O, Zymek P, Winkelmann K, et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005;96:881-9. (Pubitemid 40604972)
10. Kaikita K, Hayasaki T, Okuma T, et al. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 2004;165 :439-47. (Pubitemid 38971374)
11. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011;29 :1005-10.
12. Blum A, Sclarovsky S, Rehavia E, et al. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 1994;127 :1226-30. (Pubitemid 24176012)
13. Cheng X, Liao YH, Ge H, et al. TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 2005;25:246-53. (Pubitemid 40884051)
14. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110 :3213-20. (Pubitemid 39525068)
15. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5. This experimental study is one of the first to show that bone marrow cell therapy ameliorates outcome after acute MI in mice. (Pubitemid 32290358)
16. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15. (Pubitemid 34438914)
17. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21. One of the largest randomised clinical trials investigating bone marrow cell therapy in patients with acute MI, treated with primary percutaneous coronary intervention, reporting a beneficial effect regarding functional outcome. (Pubitemid 44427445)
18. Zimmet H, Porapakkham P, Porapakkham P, et al. Short- and longterm outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail 2012;14:91-105.
19. Lee WW, Marinelli B, van der Laan AM, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012; 59:153-63. One of the first studies unequivocally demonstrating the presence of macrophages in the remote zone after acute MI.
20. Abbate A, Bonanno E, Mauriello A, et al. Widespread myocardial inflammation and infarct-related artery patency. Circulation 2004; 110 :46-50. (Pubitemid 38880132)